Literature DB >> 27454841

Impact of sex on the clinicopathological characteristics and prognosis of papillary thyroid cancer.

Ekua Yorke1, Adrienne Melck1, Sam M Wiseman1.   

Abstract

SUMMARY: Papillary thyroid cancer (PTC) is the most common endocrine malignancy. Observed clinical and pathological differences between the sexes of PTC patients have been reported. There is currently no consensus regarding the impact of sex on PTC prognostication. We studied 566 PTC patients and observed that there was a higher PTC incidence in women, that PTC diagnosis was more challenging in women, and that men tended to present with larger cancers. However, once PTC is diagnosed, both sexes have a similar cancer prognosis, as evaluated using the MACIS (Metastasis, Age, Completeness of Resection, Invasion, Size) score. Our observations suggest that research efforts should be especially directed at improving the diagnostic yield of preoperative fine needle aspiration biopsy in women who present with nodular thyroid disease.

Entities:  

Mesh:

Year:  2016        PMID: 27454841      PMCID: PMC4961493          DOI: 10.1503/cjs.003816

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  5 in total

1.  Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.

Authors:  Catharina Ihre Lundgren; Per Hall; Paul W Dickman; Jan Zedenius
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

2.  Testosterone regulates thyroid cancer progression by modifying tumor suppressor genes and tumor immunity.

Authors:  Lisa J Zhang; Yin Xiong; Naris Nilubol; Mei He; Swaroop Bommareddi; Xuguang Zhu; Li Jia; Zhen Xiao; Jeong-Won Park; Xia Xu; Dhaval Patel; Mark C Willingham; Sheue-Yann Cheng; Electron Kebebew
Journal:  Carcinogenesis       Date:  2015-01-09       Impact factor: 4.944

3.  Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

Authors:  Xiaoguang Shi; Rengyun Liu; Fulvio Basolo; Riccardo Giannini; Xiaopei Shen; Di Teng; Haixia Guan; Zhongyan Shan; Weiping Teng; Thomas J Musholt; Khawla Al-Kuraya; Laura Fugazzola; Carla Colombo; Electron Kebebew; Barbara Jarzab; Agnieszka Czarniecka; Bela Bendlova; Vlasta Sykorova; Manuel Sobrinho-Simões; Paula Soares; Young Kee Shong; Tae Yong Kim; Sonia Cheng; Sylvia L Asa; David Viola; Rossella Elisei; Linwah Yip; Caterina Mian; Federica Vianello; Yangang Wang; Shihua Zhao; Gisele Oler; Janete M Cerutti; Efisio Puxeddu; Shen Qu; Qing Wei; Huixiong Xu; Christine J O'Neill; Mark S Sywak; Roderick Clifton-Bligh; Alfred K Lam; Garcilaso Riesco-Eizaguirre; Pilar Santisteban; Hongyu Yu; Giovanni Tallini; Elizabeth H Holt; Vasily Vasko; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2015-11-03       Impact factor: 5.958

4.  Gender differences in thyroid cancer: a critical review.

Authors:  Reina Yao; Connie G Chiu; Scott S Strugnell; Sabrina Gill; Sam M Wiseman
Journal:  Expert Rev Endocrinol Metab       Date:  2011-03

5.  Prognostic importance of various clinicopathological features in papillary thyroid carcinoma.

Authors:  L A Akslen; A O Myking; H Salvesen; J E Varhaug
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

  5 in total
  4 in total

1.  Establishment and validation of a nomogram model for predicting the survival probability of differentiated thyroid carcinoma patients: a comparison with the eighth edition AJCC cancer staging system.

Authors:  Ruyi Zhang; Mei Xu; Xiangxiang Liu; Miao Wang; Qiang Jia; Shen Wang; Xiangqian Zheng; Xianghui He; Chao Huang; Yaguang Fan; Heng Wu; Ke Xu; Dihua Li; Zhaowei Meng
Journal:  Endocrine       Date:  2021-04-06       Impact factor: 3.633

2.  Preoperative Bilirubin-Adjusted Carbohydrate Antigen 19-9 as a Prognostic Factor for Extrahepatic Cholangiocarcinoma Patients at a Single Center.

Authors:  Jiayi Li; Qiao Chen; Bao Jin; Yue Shi; Xiangan Wu; Haifeng Xu; Yongchang Zheng; Yingyi Wang; Shunda Du; Xin Lu; Yilei Mao; Xinting Sang
Journal:  Cancer Manag Res       Date:  2020-01-20       Impact factor: 3.989

3.  Male Gender Is Associated with Lymph Node Metastasis but Not with Recurrence in Papillary Thyroid Carcinoma.

Authors:  Jiang Zhu; Rui Huang; Ping Yu; Haoyu Ren; Xinliang Su
Journal:  Int J Endocrinol       Date:  2022-02-28       Impact factor: 3.257

4.  A Stepwise Approach Using Metastatic Lymph Node Ratio-Combined Thyroglobulin for Customization of [18F]FDG-PET/CT Indication to Detect Persistent Disease in Patients with Papillary Thyroid Cancer.

Authors:  Hong Hua Piao; Subin Jeon; Su Woong Yoo; Young Jae Ryu; Dong-Yeon Kim; Ayoung Pyo; Hee-Seung Bom; Jung-Joon Min; Seong Young Kwon
Journal:  Diagnostics (Basel)       Date:  2021-05-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.